Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Movsas

Showing results (141-150 of 325) with videos related to

Pageof 33
Sort By:
Medical Physics|January 10, 2025
Institutional experience with implanted cardiac device risk level assessment: Comparing calculation and measurementStephen J Gardner, Kyle Verdecchia, Brett M Miller, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12Ritsuko Komaki, R Suzanne Swann, David S Ettinger, et al.
Journal of Radiation Oncology|September 15, 2015
Radiation dose-fractionation effects in spinal cord: comparison of animal and human dataJian-Yue Jin, Yimei Huang, Stephen L Brown, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancerSteven J Feigenberg, Alexandra L Hanlon, Corey Langer, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2010
Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology GroupMitchell Machtay, Kyounghwa Bae, Benjamin Movsas, et al.
International Journal of Radiation Oncology, Biology, Physics|May 27, 2008
Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801Linda Sarna, Suzanne Swann, Corey Langer, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2020
Characteristics of Participation in Patient-Reported Outcomes and Electronic Data Capture Components of NRG Oncology Clinical TrialsStephanie L Pugh, Joseph P Rodgers, Katherine A Yeager, et al.
Medical Physics|December 20, 2019
Application of radiomics for the prediction of HPV status for patients with head and neck cancersHassan Bagher-Ebadian, Mei Lu, Farzan Siddiqui, et al.
Head & Neck|December 10, 2013
Outcomes toolbox for head and neck cancer researchJolie Ringash, Lori J Bernstein, David Cella, et al.
Translational Medicine Communications|April 17, 2023
Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford HealthShivani Thoidingjam, Sushmitha Sriramulu, Svend Freytag, et al.
Pageof 33

Showing results (141-150 of 325) with videos related to

Sort By:
Pageof 33
Medical Physics|January 10, 2025
Institutional experience with implanted cardiac device risk level assessment: Comparing calculation and measurementStephen J Gardner, Kyle Verdecchia, Brett M Miller, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12Ritsuko Komaki, R Suzanne Swann, David S Ettinger, et al.
Journal of Radiation Oncology|September 15, 2015
Radiation dose-fractionation effects in spinal cord: comparison of animal and human dataJian-Yue Jin, Yimei Huang, Stephen L Brown, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancerSteven J Feigenberg, Alexandra L Hanlon, Corey Langer, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2010
Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology GroupMitchell Machtay, Kyounghwa Bae, Benjamin Movsas, et al.
International Journal of Radiation Oncology, Biology, Physics|May 27, 2008
Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801Linda Sarna, Suzanne Swann, Corey Langer, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2020
Characteristics of Participation in Patient-Reported Outcomes and Electronic Data Capture Components of NRG Oncology Clinical TrialsStephanie L Pugh, Joseph P Rodgers, Katherine A Yeager, et al.
Medical Physics|December 20, 2019
Application of radiomics for the prediction of HPV status for patients with head and neck cancersHassan Bagher-Ebadian, Mei Lu, Farzan Siddiqui, et al.
Head & Neck|December 10, 2013
Outcomes toolbox for head and neck cancer researchJolie Ringash, Lori J Bernstein, David Cella, et al.
Translational Medicine Communications|April 17, 2023
Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford HealthShivani Thoidingjam, Sushmitha Sriramulu, Svend Freytag, et al.
Pageof 33